RDHL Redhill Biopharma Ltd. - American Depositary Shares
RDHL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
RDHL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
RDHL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2022 | $-200.00 | $-30.60 | -169.4% |
| March 31, 2022 | $-300.00 | $-234.60 | -65.4% |
| Dec. 31, 2021 | $-500.00 | $-336.60 | -163.4% |
| Sept. 30, 2021 | $-500.00 | $-210.80 | -289.2% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| RDHL | — | — | — | — | — | — |
| SPRC | — | — | — | — | — | — |
| PRFX | — | — | — | — | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 15 filers · $270K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 (0 vs prior Q) | 4 (0 vs prior Q) | 5 (+1 vs prior Q) | 1 (0 vs prior Q) | -202K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | $106,681 | 122,131 | 39.51% | Shares |
| GAGNON SECURITIES LLC | $74,702 | 88,405 | 27.67% | Shares |
| CITADEL ADVISORS LLC | $55,196 | 65,321 | 20.44% | Shares |
| RHUMBLINE ADVISERS | $11,620 | 13,755 | 4.30% | Shares |
| Lido Advisors, LLC | $9,303 | 11,009 | 3.45% | Shares |
| GAMMA Investing LLC | $5,879 | 6,957 | 2.18% | Shares |
| CITIGROUP INC | $3,699 | 4,378 | 1.37% | Shares |
| Federation des caisses Desjardins du Quebec | $2,863 | 3,388 | 1.06% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $42 | 50 | 0.02% | Shares |
| SBI Securities Co., Ltd. | $13 | 15 | 0.00% | Shares |
| Smartleaf Asset Management LLC | $4 | 5 | 0.00% | Shares |
| Vermillion Wealth Management, Inc. | $2 | 2 | 0.00% | Shares |
| UBS Group AG | $2 | 2 | 0.00% | Shares |
| MORGAN STANLEY | $1 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 351 | 0.00% | Shares |
Company insiders 1 insider · 1 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Gilead Raday | Chief Operating Officer | July 10, 2026 M | 218,780,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Quintairos, Prieto, Wood & Boyer P.A. | Aug. 7, 2024 | 0.00% | Initial filing | — | SEC |
| Dr. Shmuel Cabilly ×3 filings | Feb. 16, 2016 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.